Rofaday 500 mcg
Rofaday 500 mcg is a prescription treatment for the severe chronic obstructive pulmonary disease (COPD) in adults. It is extremely effective in reducing inflammation of airways, blockage in lungs and other related conditions. The active ingredient of the medicine is Roflumilast, which controls and prevents symptoms of COPD. These symptoms include wheezing, coughing and shortness of breath. Your doctor may prescribe Rofaday with other bronchodilators such as ipratropium or salmeterol to reduce inflammation to treat COPD. This medication must be used regularly to achieve the maximum results. It does not help with sudden shortness of breath or wheezing. If sudden breathing issues occur, use your quick-relief inhaler prescribed by your doctor. Your doctor may prescribe you albuterol, also called salbutamol to ger rid of sudden breathing problems.
Uses of Rofaday 500 mcg
Rofaday 500 mcg has been approved for the prevention of chronic obstructive disease or COPD. Roflumilast, a phosphodiesterase 4 inhibitor is the active ingredient of the medicine. It effectively targets important goals in the management of COPD such as symptoms relief and reduction of COPD exacerbations. This PDE4 inhibitor has raised hope for more effective COPD treatment. It works by reducing inflammation in the lungs and blockage in the airways, which makes it easier for the patient to breathe.
Read the doctor’s prescription carefully. If you have questions, ask your doctor. Rofaday 500 mcg is available in the form of a tablet. Usually, it is taken once daily with or without food. Roflumilast 500 mcg is enough to reduce the risk of COPD exacerbation in patients with severe COPD. Use this medication to get the most benefit out of it. Make sure you take it at evenly spaced intervals. Do not alter the dosage regimen without first consulting your doctor. The risk of administering this medicine to patients with liver disease should be considered.
Rofaday is not a bronchodilator, therefore it should not be used to gain control over acute bronchospasm. The safety and effectiveness of the drug have not been established in patients less than 18 years of age.
Possible Side Effects
Clinical data revealed an increase in adverse psychiatric reactions in COPD patients who used Rofaday 500 mcg. It is advisable to carefully weigh the risks and benefits of medicine in patients with a history of depression and other mental conditions. One should observe for symptoms such as insomnia, suicidal thoughts, anxiety, depression and other mood changes developed while taking medicine. If you find any often issues mentioned above, consult our doctor, he/she will evaluate the risks and benefits of continuing Rofaday. Weight loss is also a common side effect associated with the use of Roflumilast. Users are instructed to keep a close eye on their weight during the treatment. If unexplained weight loss is the issue, then discontinuation of the drug should be considered. But make sure you consult your doctor before making any decision regarding the medicinal use.